Segment Information

9 Months Ended

Mar. 30, 2013

Segments and Geographic Information [Abstract]

Segment Information [Text Block]

SEGMENT INFORMATION

The Company has four reportable segments, aligned primarily by type of product: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals and API, along with an Other category. The accounting policies of each segment are the same as those described in the summary of significant accounting policies set forth in Note 1. The majority of corporate expenses, which generally represent shared services, are charged to operating segments as part of a corporate allocation. Unallocated expenses relate to certain corporate services that are not allocated to the segments.

From time-to-time, the Company evaluates its estimates of the allocation of shared service support functions to its reportable segments. In the first quarter of fiscal 2013, management revised its allocation estimates to better reflect the utilization of shared services by segment. Management believes the update of the allocation estimates results in a more appropriate measure of earnings for each segment. This change is consistent with how the chief operating decision maker reviews segment results. Prior period results from operations have been updated to reflect the change in the Company's allocation estimates. This change had no effect on consolidated results of operations.

	Consumer Healthcare		Nutritionals		Rx Pharmaceuticals		API		Other		Unallocated expenses			Total
Three Months Ended March 30, 2013
Net sales	$	536,775	$	133,344	$	189,410	$	41,114	$	19,182	$	—		$	919,825
Operating income	$	95,921	$	6,965	$	73,419	$	11,728	$	1,642	$	(11,069	)	$	178,606
Amortization of intangibles	$	5,030	$	7,310	$	11,351	$	498	$	423	$	—		$	24,612
Total assets	$	1,724,585	$	951,113	$	1,433,788	$	278,957	$	107,445	$	—		$	4,495,888
Three Months Ended March 31, 2012
Net sales	$	448,848	$	117,683	$	155,591	$	36,951	$	18,944	$	—		$	778,017
Operating income	$	79,383	$	1,845	$	67,257	$	10,462	$	846	$	(13,723	)	$	146,070
Amortization of intangibles	$	2,421	$	6,637	$	8,574	$	490	$	410	$	—		$	18,532
Total assets	$	1,658,231	$	952,761	$	1,066,559	$	266,786	$	95,717	$	—		$	4,040,054

	Consumer Healthcare		Nutritionals		Rx Pharmaceuticals		API		Other		Unallocated expenses			Total
Nine Months Ended March 30, 2013
Net sales	$	1,526,479	$	358,705	$	514,893	$	118,387	$	54,130	$	—		$	2,572,594
Operating income	$	261,287	$	18,008	$	205,982	$	38,867	$	2,730	$	(27,838	)	$	499,036
Amortization of intangibles	$	12,163	$	21,920	$	28,210	$	1,442	$	1,223	$	—		$	64,958
Nine Months Ended March 31, 2012
Net sales	$	1,331,806	$	365,691	$	460,414	$	127,347	$	56,224	$	—		$	2,341,482
Operating income	$	230,822	$	13,638	$	161,716	$	36,370	$	2,055	$	(36,311	)	$	408,290
Amortization of intangibles	$	6,886	$	22,739	$	23,896	$	1,507	$	1,285	$	—		$	56,313